Other Members

Read More.

His key research interests include preventive oncology in relation to cervical cancer.
Read More.

Her current research focuses on strategies to eliminate cervical cancer in low resource setting and impact of HPV vaccination in cervical cancer screening.

Read More.

His area of expertise resides mainly in Drug development, Translational Glycoimmunology, Proteomics and Glycomics in gynaecological cancer.
Read More.

Santu Kumar Saha: He is currently pursuing an Newton Fellowship under the supervision of Professor Nicola Curtin at Newcastle University and in collaboration with Asima Mukhopadhyay, KolGOTrg.His work includes hypoxia and radiosensitization using PARP inhibitors in cervical cancers.
Read More.

Her previous research work includes basic and translational studies in cervical cancer. Currently she is working on DDR in ovarian cancer at Newcastle University and in collaboration with Asima Mukhopadhyay, KolGOTrg.
Read More.

Her key research interest includes neuro-inflammation, immunology and cancer biology in relation to cervical and ovarian cancer.

Read More.

Her previous and current research interest includes cervical cancer preventions.
Read More.

His key research interest includes cellular metabolism in ovarian cancer and therapeutic targets.

Her key research area focuses on clinical trials in relation to ovarian and cervical cancer.
Read More.

Unit head and Incharge Genital Cancer control Unit, King George’s Medical University, Lucknow
Vice President Association of Gyne Oncologists of India
Vice President Lucknow Obstetrics and Gynaecology Society
Read More.

Dr. Damayanti Das Ghosh is presently studying whether any correlation is present between stemness and presence of GOF mutant p53 and, whether such correlation is associated with chemoresistance in high grade serous ovarian cancer. Her second work is related to developing organoids from ovarian and cervical tumors. In cancer research, organoids can be used for both studying basic biology of the disease and for testing drug-sensitivity. She is also working on TCGA Data-mining on ovarian and endometrial cancer. Read More.

His key research area focuses on clinical trials in relation to ovarian and cervical cancers.
Read More.

Dr Biswarup Basu is Senior Scientific Officer at CNCI and his area of interest is deciphering neuronal regulations on cancer progression. He is engaged in identifying key proteins in autophagy and neuro-endocrine pathways that may serve as potential biomarkers and targets against cancer metastasis in breast and ovarian cancers. Dr Basu is also working on natural compounds with anticancer properties in ovarian tumor models. His other research interest involves the development of biomaterials to accelerate wound healing and facilitate sustained delivery of oral drugs. Read More.

Her key research area focuses on clinical trials in relation to ovarian and cervical cancers.
Read More.

Read More.

His key research area focuses on clinical trials in relation to ovarian and cervical cancers.
Read More.

Adequately trained in management of all Gynaecologic malignancies, pre-invasive conditions, colposcopy and screening tests. Read More

Kailash Narayan a Gynaecological Radiation Oncologist and Professor at the Department of Obstetrics & Gynaecology, University of Melbourne, Australia. He had training in medicine, Biophysics, Experimental pathology and Radiation Oncology. His laboratory research interests have been microvasculature of normal and neoplastic tissues. His clinical research interests have been in the application of histology, MRI and PET in prognosticating and management of gynaecological cancers. His longitudinal observational studies since 1996 have been the source for assessing various radiological and histological prognostic factors and treatment outcomes, showing the highest quality of care and a marked reduction in radiotherapy complications. His observations became the basis of selection of patients for clinical studies. Based on his experimental observations of vascular response to radiation and later clinical observations of cancer treatment failure patterns he hypothesized that tumour cell dissemination could result from the tumour disruption caused by the treatment itself. Read More

Read More.

Dr shashi Kala Tiwary is a highly qualified Obstetrician and Gynaecologist with 1.2 Decades of service experience. She is a member of World Laparoscoy Hospital with experty in Laparoscopy, infertility and general obstetrics and cosmetic gynae. She is a member of KOLGOTRG with special contribution in women Cancer Screening and observership in Preventive Oncology from Tata Medical Centre, Kolkata. Read More

Read More

Read More.

We have lost one of our members Dr. Gouri Sankar Bhattacharyya. He was a renowned oncologist. Due to covid-19, Dr. Bhattacharyya died on April 30, 2021. We pray for his soul to rest in peace. Read More

Global Phase -3 Clinical Trial on Ovarian Cancer is in Progress (Patient Recruitment ongoing). (01/21 to
01/24); Global Phase-2 open label basket study on NSCLC & DLBCL is in progress ( Patient recruitment yet to
start); Survey on Out of Hospital Cardiac Arrest registry (OHCA) and its impact during covid-19 in India (07/21
to 07-23); Awareness of Breast Cancer in different slum areas in Mumbai, (03/19 to 08/19)
PhD Guide: Currently 2 students are working under my supervision in the PhD Program.
Author IDs https://orcid.org/0000-0002-2010-7409; Researcher ID: A-3455-2012; Scopus Author ID:
35444747600
There are 27 peer reviewed Journal Published in several high impact international journals. Read More

IGCS Travel Fellowship in Gynecological Oncology at University College Hospital London (2016)

AWARDS / ACHIEVEMENTS
1. Harold A Kaminetzky Prize Paper 2013 – Best Research Article by
a Non-US Researcher. Presented in Annual Conference of ACOG at
Chicago, April 2014
2. IGCS Travel Fellowship Award 2016
3. Faculty Trainer – Vocational Teaching & Training Mission to
Mongolia by Rotary International. 26th August – 8th Sep. 2017
4. Associate Editor, India Journal of Obstetrics & Gynecology Research  Read More..

MBBS, MD (General Medicine),
DM (Medical Oncology)
Designation: Assistant Professor, Medical Oncology
Institute: National Cancer Institute-AIIMS, Jhajjar Read More..

Work Experience:
• Senior Consultant & Unit Head Gynae Oncology: Department of
Surgical Oncology, RGCIRC, Delhi- July 1,2023 till date.
• Consultant Gynae Oncology: Department of Surgical Oncology, Rajiv
Gandhi Cancer Institute and Research Centre, Delhi-January 2, 2018 till
date.
• Fellow: Department of Gynae Oncology, Rajiv Gandhi Cancer
Institute and Research Centre, Delhi – January 2, 2017 till January 1
2018. Read More..

HONORS AND AWARDS:

1. Best student award in Senior Secondary School and High School
2. Winner of 25th Indian Academy of Pediatrics quiz for undergraduates (institutional round), July 2012
3. Runner up in 25th Indian Academy of Pediatrics quiz for undergraduates (divisional round), August 2012
4. Second prize in All India Medical Quiz at AIIMS in September 2012
5. Second runner in paper presentation at AGOICON in November 2018
6. Selected as “Young doc from India” for ASGO workshop in 2018 at Seoul Korea Read More..

Dr Nilanchali Singh is Associate Professor in the department of Obstetrics and Gynecology at the All India Institute of Medical Sciences (AIIMS), New Delhi with special interests in research related to gynaecologic oncology, preventive and community oncology. Remaining in a public institution, she aspires to work on women public health related matters, cervical cancer screening being one of them. Dr Singh has many projects, funded by various national (ICMR, DST, SERB) and international (ASCO) bodies and more than 100 publications to her credit. She is a member of International Papilloma Virus Society (IPVS) Early Career Working Group. Read More

Projects undertaken in the last 5 years (brief title, funding source, amount, status)
1. Sertoli Leydig cell tumors of the ovary, clinical presentations and outcomes JSAC/96/2021/062- As PI-Not Funded- Published
2. Comparison of 2-year recurrence free survival among women with locally advanced uterine cervical cancer with and without early clearance of high risk human papillomavirus after complete response with chemoradiation JIP/IEC/2021/136- Intramural Funding- Amount- 6,21,040- Ongoing as Co-PI  Read More

WORKED IN DEPT OF OBSTERICS & GYNECOLOGY SINCE APRIL, 1998 TILL OCTOBER ,2004- AT HYDERABAD (KAMINENI HOSPITALS, CDR HOSPITALS), AT DHANBAD, JHARIA, JAMADOBA -COLLIERY HOSPITAL OF TATA STEEL, INDRAPRASTHA APOLLO HOSPITAL, NEW DELHI, ST. PHILOMENA’S HOSPITAL, BANGALORE. I HAD WORKED AS SENIOR RESIDENT, LATER, AS CONSULTANT IN OBSTERICS & GYNECOLOGY, IN THESE HOSPITALS. Read More

WORK EXPERIENCE:
1)  Junior resident (Jan 2016 – Dec 2018)
Department of obstetrics and gynaecology,
PGIMER Chandigarh.

2)  Registrar (Jul 2019 – Sept 2019)
Department of obstetrics and gynaecology,
Bangalore Baptist Hospital, Bengaluru.   Read More

1. Residency in Ob-Gyn from Lala Lajpat Rai Memorial Medical College, Meerut, India (2004-2007).
2.  Senior Residency in Ob-Gyn at Jag Pravesh Chandra Hospital, Delhi (01/15/08 – 05/08/08)
3. Senior Residency in Ob-Gyn at University College of Medical Sciences and Guru Tegh Bahadur Hospital, New Delhi, India (05/09/08 – 01/15/11) Read More

MGMMC M Y Hospital, Indore, Madhya Pradesh, India(Junior Residency)
LHMC, New Delhi, India (senior residency)
KGMU, Lucknow, Uttar Pradesh, India, (senior residency)
ELMC, Lucknow, Uttar Pradesh, India, (senior residency)
Program- M.S and Senior residency Read More

Her key interest include sialoglycobiology of cancer and futuristic therapy using herbal molecules to meet unmet needs in ovarian/cervical cancer. Read More

Honorary Visiting Faculty Sr. Assistant Director Grade (Retd.) Head, Dept. of Oncogene Regulation Chittaranjan National Cancer Institute. Read More

He is a prominent member of several organisations such as Association of Radiation Oncologists of India (AROI),Indian Society of Oncology (ISO), American Society of ClinicalOncology,European Society of Medical Oncology & International Association of Study of Lung Cancer as well as KolGOTrg. Read More